Doongaji D R, Satoskar R S, Sheth A S, Apte J S, Desai A B, Shah B R
J Postgrad Med. 1989 Jan;35(1):3-8.
Twenty-nine acute schizophrenic patients were treated under double-blind conditions for six weeks with either centbutindole in a dose range of 3 mg/day to 4.5 mg/day or trifluoperazine in the dose range of 15 mg/day to 22.5 mg/day. Both drugs produced a significant improvement in initial psychopathology. No significant differences were demonstrated between the two treatment conditions.
29名急性精神分裂症患者在双盲条件下接受为期六周的治疗，分别服用剂量范围为3毫克/天至4.5毫克/天的森布替林或剂量范围为15毫克/天至22.5毫克/天的三氟拉嗪。两种药物均使初始精神病理学症状有显著改善。两种治疗条件之间未显示出显著差异。
